Literature DB >> 9064767

[Placental location and incidence of pre-eclampsia].

M Gonser1, N Tillack, K H Pfeiffer, G Mielke.   

Abstract

AIM: In pregnancies with unilateral placental location, the uteroplacental Doppler flow measurements show significant side-to-side differences. Highly divergent findings seem to be associated with an unfavourable outcome, particularly with preeclampsia. Therefore, we studied the relationship between placental location and subsequent development of preeclampsia prospectively.
METHOD: 184 patients between 24 and 36 weeks of gestation were studied prospectively. Placental location was classified as central or lateral by ultrasound. Preeclampsia was defined by blood pressure > or = 140/90 mmHg and proteinuria > or = 500 mg/24 h.
RESULTS: After consideration of exclusion criteria, 148 pregnancies could be evaluated: 115 had a laterally and 33 a centrally located placenta. The incidence of preeclampsia in these groups was 32/115 (28%) and 3/33 (9%) respectively.
CONCLUSION: These data suggest that a laterally located placenta is associated with a significantly increased incidence of preeclampsia, with a risk ratio of 3.1 when compared to pregnancies with centrally located placentas.

Entities:  

Mesh:

Year:  1996        PMID: 9064767     DOI: 10.1055/s-2007-1003188

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  2 in total

1.  High-end arteriolar resistance limits uterine artery blood flow and restricts fetal growth in preeclampsia and gestational hypertension at high altitude.

Authors:  Vaughn A Browne; Lilian Toledo-Jaldin; R Daniela Davila; Luis P Lopez; Henry Yamashiro; Darleen Cioffi-Ragan; Colleen G Julian; Megan J Wilson; Abigail W Bigham; Mark D Shriver; Benjamin Honigman; Enrique Vargas; Robert Roach; Lorna G Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-16       Impact factor: 3.619

2.  Considering intrauterine location in a model of fetal growth restriction after maternal titanium dioxide nanoparticle inhalation.

Authors:  J N D'Errico; S B Fournier; P A Stapleton
Journal:  Front Toxicol       Date:  2021-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.